Posted by
Dry eye medication wins FDA approval

Dry eye medication wins FDA approval

Drug regulators in the United States have approved Xiidra, which is lifitegrast ophthalmic solution 5 percent, to treat dry eye disease. Xiidra is the first prescription eye drop approved to treat both the signs and symptoms of dry eye – a group of conditions where the tear fluid produced by the eyes is either insufficient […]

Posted by
Zika warnings lead to significant increase in demand for abortions in Latin America

Zika warnings lead to significant increase in demand for abortions in Latin America

Health warnings about complications related to Zika virus significantly increased demand for abortions in Latin American countries, according to a new study published in the New England Journal of Medicine. However, in many of these countries, abortion is either illegal or highly restricted, leaving pregnant women with few options and potentially driving women to use […]

Posted by
Abortion rates at all-time low in developed countries but remain unchanged in developing countries

Abortion rates at all-time low in developed countries but remain unchanged in developing countries

Abortion rates have declined significantly over the last 25 years in developed countries and are at a historic low. But in developing countries, where many abortions are unsafe, rates have remained level, highlighting the urgent need for better access to modern contraception (eg, hormonal pill, implants, IUDs) to reduce unwanted pregnancies and abortions. The new […]

Posted by
Threat of novel swine flu viruses in pigs and humans

Threat of novel swine flu viruses in pigs and humans

The wide diversity of flu in pigs across multiple continents, mostly introduced from humans, highlights the significant potential of new swine flu strains emerging, according to a study to be published in eLife. While swine flu viruses have long been considered a risk for human pandemics, and were the source of the 2009 pandemic H1N1 […]

Posted by
UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, have announced the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models. They published their findings recently in the Journal of Virology. Researchers from UGA and Sanofi Pasteur, which has a […]